Galmed Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell GLMD and other ETFs, options, and stocks.About GLMD
Galmed Pharmaceuticals Ltd. is a clinical-stage drug development biopharmaceutical company, which engages in the development of oral therapy for the treatment of non-alcoholic steato-hepatitis (NASH). Its product candidate, Aramchol, is a synthetic fatty acid-bile acid conjugate molecule for the oral treatment of NASH in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
CEOAllen J. Baharaff
CEOAllen J. Baharaff
Employees6
Employees6
HeadquartersRamat Gan, Tel Aviv
HeadquartersRamat Gan, Tel Aviv
Founded2000
Founded2000
Employees6
Employees6
GLMD Key Statistics
Market cap5.75M
Market cap5.75M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume222.13K
Average volume222.13K
High today$1.09
High today$1.09
Low today$1.02
Low today$1.02
Open price$1.06
Open price$1.06
Volume92.14K
Volume92.14K
52 Week high$3.61
52 Week high$3.61
52 Week low$0.7449
52 Week low$0.7449
Stock Snapshot
The current Galmed Pharmaceuticals(GLMD) stock price is $1.02, with a market capitalization of 5.75M. The stock trades at a price-to-earnings (P/E) ratio of -0.30.
On 2025-12-12, Galmed Pharmaceuticals(GLMD) stock moved within a range of $1.02 to $1.09. With shares now at $1.02, the stock is trading 0.0% above its intraday low and -6.4% below the session's peak.
Trading volume for Galmed Pharmaceuticals(GLMD) stock has reached 92.14K, versus its average volume of 222.13K.
The stock's 52-week range extends from a low of $0.74 to a high of $3.61.
The stock's 52-week range extends from a low of $0.74 to a high of $3.61.
People also own
Based on the portfolios of people who own GLMD. This list is generated using Robinhood data, and it’s not a recommendation.